Angioplasty no better than drugs for pre-heart attack patients, study finds - Los Angeles Times
It's pretty fascinating how a new medical procedure seems to take off in popularity with doctors, well before the studies are in that properly compare it with other treatments. The story above is a fine example.
I was also surprised to see just how much money in the stent business:
The findings deal another significant blow to the stent industry, which sells an estimated $3.2-billion worth of stents each year in the United States. As many as 65% of the estimated 1 million stenting procedures performed each year occur in such patients at a cost of about $40,000 per surgery.
That's a lot of money on bits of metal that don't seem so effective (at least for pre-heart attack patients) after all.